Delivery Order SPE2DB24D2106-SPE2DB24FATZY
Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,059.42 contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,409.68 contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, which will be completed by February 26, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,807.60 firm fixed-price contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue...
- This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,409.68, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine syringes (0.5mL) under a firm fixed-price contract. This delivery order, valued at $13,922.86 with an ultimate completion date of July 21, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,114.52 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge. The delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,136.56 for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. It is a firm fixed-price contract with an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $7,387.64, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a performance period through April 28, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...